NCT07627633

Brief Summary

The purpose of this clinical study is to evaluate the clinical and radiographic efficacy of Theravex Tissue Care Plus (Bone Bioactive Liquid) as an adjunct to a xenograft in crestal maxillary sinus elevation with simultaneous implant placement using the osseodensification technique. The study will enroll 16 partially edentulous patients who have inadequate posterior maxillary bone height. Participants will randomly undergo the sinus elevation and implant placement utilizing either a xenograft alone or a mixture of the xenograft and Theravex. The main question the study aims to answer is whether the adjunctive use of Theravex with a xenograft enhances vertical bone gain, bone density, and implant stability compared to using a xenograft alone.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
31mo left

Started Oct 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 30, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 4, 2026

Completed
4 months until next milestone

Study Start

First participant enrolled

October 1, 2026

Expected
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2028

7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2029

Last Updated

June 4, 2026

Status Verified

May 1, 2026

Enrollment Period

2 years

First QC Date

May 30, 2026

Last Update Submit

May 30, 2026

Conditions

Keywords

Bone Bioactive LiquidTheravex Tissue CareInternal Sinus LiftingImplantXenograftSinus augmentation

Outcome Measures

Primary Outcomes (1)

  • Implant Stability Quotient (ISQ)

    ISQ will be recorded at baseline immediately post-operative. Repeating ISQ measurements will be taken for 3 months post-operatively to evaluate the transition from primary to secondary stability

    Immediate post-operative and 3 months post-operative

Secondary Outcomes (3)

  • Bone Density

    Immediate post-operative and 6 months post-operative

  • Vertical Bone Gain

    Immediate post operative and 6 months after surgery

  • Oral-health-related quality of life OHIP-14

    Baseline (before surgery), 7 days, 3 months and 6 months post-operative.

Study Arms (2)

Theravex - Xenograft mixture group

EXPERIMENTAL

Patients in this group will undergo internal maxillary sinus lift via the osseodensification technique with simultaneous dental implant placement, utilizing a mixture of Theravex (Bone Bioactive Liquid) and xenograft and as the grafting material.

Biological: Internal Sinus lifting using Theravex-Xenpgraft mixture

Xenograft alone group

ACTIVE COMPARATOR

Patients in this group will undergo internal maxillary sinus lift via the osseodensification technique with simultaneous dental implant placement, utilizing xenograft alone as the grafting material.

Biological: Internal Sinus lifting using Xenpgraft alone

Interventions

Application of a grafting mixture consisting of an equine granulate xenograft hydrated with Theravex (Bone Bioactive Liquid) into the osteotomy site.

Theravex - Xenograft mixture group

Application of an equine granulate xenograft alone into the osteotomy site.

Xenograft alone group

Eligibility Criteria

Age21 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Patient partially edentulous with maxillary posterior edentulous ridge after extraction of more than 4 months.
  • Both genders will be selected males and females.
  • Adult patients aged between 21 and 50 years of age.
  • Good general health (American Society of Anesthesiology Physical Status I-II).
  • Initial residual alveolar ridge height ranging between 4 to 6 mm according to preoperative CBCT.
  • No previous surgery or radiation treatment on the maxillary sinus

You may not qualify if:

  • Smokers
  • Pregnant and lactating females.
  • Poor oral hygiene (Full-Mouth Plaque Score (FMPS) \> 20%).
  • Patients with occlusal or malalignment problems.
  • Patients with parafunctional habits.
  • Presence of acute or chronic sinus pathoses or sinus membrane perforation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Dentistry Ain Shams university

Cairo, 11566, Egypt

Location

Related Publications (27)

  • Zizelmann C, Schoen R, Metzger MC, Schmelzeisen R, Schramm A, Dott B, Bormann KH, Gellrich NC. Bone formation after sinus augmentation with engineered bone. Clin Oral Implants Res. 2007 Feb;18(1):69-73. doi: 10.1111/j.1600-0501.2006.01295.x.

    PMID: 17224026BACKGROUND
  • Yan Q, Wu X, Su M, Hua F, Shi B. Short implants (</=6 mm) versus longer implants with sinus floor elevation in atrophic posterior maxilla: a systematic review and meta-analysis. BMJ Open. 2019 Oct 28;9(10):e029826. doi: 10.1136/bmjopen-2019-029826.

    PMID: 31662363BACKGROUND
  • Won YH, Kim SG, Oh JS, Lim SC. Clinical evaluation of demineralized bone allograft for sinus lifts in humans: a clinical and histologic study. Implant Dent. 2011 Dec;20(6):460-4. doi: 10.1097/ID.0b013e31823541e7.

    PMID: 21986455BACKGROUND
  • Wallace SS, Froum SJ. Effect of maxillary sinus augmentation on the survival of endosseous dental implants. A systematic review. Ann Periodontol. 2003 Dec;8(1):328-43. doi: 10.1902/annals.2003.8.1.328.

    PMID: 14971260BACKGROUND
  • Testori T, Weinstein T, Taschieri S, Wallace SS. Risk factors in lateral window sinus elevation surgery. Periodontol 2000. 2019 Oct;81(1):91-123. doi: 10.1111/prd.12286.

    PMID: 31407430BACKGROUND
  • Tatum H Jr. Maxillary and sinus implant reconstructions. Dent Clin North Am. 1986 Apr;30(2):207-29.

    PMID: 3516738BACKGROUND
  • Starch-Jensen T, Ostergaard KB, Bruun NH, Shino IL, Hallund MH. Transcrestal Maxillary Sinus Membrane Elevation using Osseodensification Compared with Alveolar Ridge Augmentation using the Lateral Window or Osteotome Technique: a Systematic Review and Meta-Analysis. J Oral Maxillofac Res. 2025 Jun 30;16(2):e1. doi: 10.5037/jomr.2025.16201. eCollection 2025 Apr-Jun.

    PMID: 40693126BACKGROUND
  • Starch-Jensen T, Bruun NH, Spin-Neto R. Outcomes following osteotome-mediated sinus floor elevation with Bio-Oss Collagen or no grafting material: a one-year single-blind randomized controlled trial. Int J Oral Maxillofac Surg. 2023 Sep;52(9):988-997. doi: 10.1016/j.ijom.2022.12.009. Epub 2023 Jan 12.

    PMID: 36639342BACKGROUND
  • Song P, He D, Ren S, Fan L, Sun J. Platelet-rich fibrin in dentistry. J Appl Biomater Funct Mater. 2024 Jan-Dec;22:22808000241299588. doi: 10.1177/22808000241299588.

    PMID: 39588592BACKGROUND
  • Summers RB. A new concept in maxillary implant surgery: the osteotome technique. Compendium. 1994 Feb;15(2):152, 154-6, 158 passim; quiz 162.

    PMID: 8055503BACKGROUND
  • Neiva, R., Tanello, B., Duarte, W., & Silva, F. (2018). Osseodensification crestal sinus floor elevation with or without synthetic and resorbable calcium phosphosilicate putty. Clinical Oral Implants Research, 29(S17), 446-446

    BACKGROUND
  • Mansour, A., Al-Hamed, F. S., Torres, J., & Marino, F. T. (2020). Alveolar bone grafting: Rationale and clinical applications. Dental Implants and Bone Grafts: Materials and Biological Issues, 43-87

    BACKGROUND
  • Levi I, Halperin-Sternfeld M, Horwitz J, Zigdon-Giladi H, Machtei EE. Dimensional changes of the maxillary sinus following tooth extraction in the posterior maxilla with and without socket preservation. Clin Implant Dent Relat Res. 2017 Oct;19(5):952-958. doi: 10.1111/cid.12521. Epub 2017 Jul 26.

    PMID: 28745002BACKGROUND
  • Kuo PY, Lin CY, Chang CC, Wang YM, Pan WL. Grafted bone remodeling following transcrestal sinus floor elevation: A cone-beam computed tomography study. Biomed J. 2021 Oct;44(5):627-635. doi: 10.1016/j.bj.2020.05.011. Epub 2020 May 26.

    PMID: 34740571BACKGROUND
  • Kim YK, Hwang JY, Yun PY. Relationship between prognosis of dental implants and maxillary sinusitis associated with the sinus elevation procedure. Int J Oral Maxillofac Implants. 2013 Jan-Feb;28(1):178-83. doi: 10.11607/jomi.2739.

    PMID: 23377064BACKGROUND
  • Huwais S, Mazor Z, Ioannou AL, Gluckman H, Neiva R. A Multicenter Retrospective Clinical Study with Up-to-5-Year Follow-up Utilizing a Method that Enhances Bone Density and Allows for Transcrestal Sinus Augmentation Through Compaction Grafting. Int J Oral Maxillofac Implants. 2018 Nov/Dec;33(6):1305-1311. doi: 10.11607/jomi.6770.

    PMID: 30427961BACKGROUND
  • Hashem, A. H., Khedr, M. F., Hosny, M. M., El-Destawy, M. T., & Hashem, M. I. (2023). Effect of Different Crestal Sinus Lift Techniques for Implant Placement in the Posterior Maxilla of Deficient Height: A Randomized Clinical Trial. Applied Sciences 2023, Vol. 13, Page 6668, 13(11), 6668

    BACKGROUND
  • Gong T, Wang LQ, Tong X, Zhang Y, Shu LJ. Impact of Age-Related Bone Density Variations on Dental Implant Stability and Success Rates: A Retrospective Analysis. Int Dent J. 2025 Dec;75(6):103942. doi: 10.1016/j.identj.2025.103942. Epub 2025 Oct 18.

    PMID: 41110400BACKGROUND
  • Garoushi, I., mehdawi, manaaer, Aldarnawi, F., Elmake, F., BenAli, N., & Othman, elsanousi. (2025). Awareness toward dental implants as a treatment option for replacement of missing teeth : A Cross-sectional study. Ain Shams Dental Journal, 37, 141-147

    BACKGROUND
  • Ferres-Amat E, Al Madhoun A, Ferres-Amat E, Carrio N, Barajas M, Al-Madhoun AS, Ferres-Padro E, Marti C, Atari M. Comparison of 0.12% Chlorhexidine and a New Bone Bioactive Liquid, BBL, in Mouthwash for Oral Wound Healing: A Randomized, Double Blind Clinical Human Trial. J Pers Med. 2022 Oct 16;12(10):1725. doi: 10.3390/jpm12101725.

    PMID: 36294864BACKGROUND
  • Elghobashy MTM, Shaaban AM, Melek LNF. Radiographic comparison between Densah burs and osteotome for graftless internal sinus lifting with simultaneous implant placement: a randomized clinical trial. Int J Oral Maxillofac Surg. 2023 Mar;52(3):388-395. doi: 10.1016/j.ijom.2022.06.020. Epub 2022 Jul 13.

    PMID: 35840446BACKGROUND
  • Del Fabbro M, Corbella S, Weinstein T, Ceresoli V, Taschieri S. Implant survival rates after osteotome-mediated maxillary sinus augmentation: a systematic review. Clin Implant Dent Relat Res. 2012 May;14 Suppl 1:e159-68. doi: 10.1111/j.1708-8208.2011.00399.x. Epub 2011 Nov 14.

    PMID: 22082056BACKGROUND
  • Carreno Carreno J, Aguilar-Salvatierra A, Gomez-Moreno G, Garcia Carreno EM, Menendez Lopez-Mateos ML, Perrotti V, Piattelli A, Calvo-Guirado JL, Menendez-Nunez M. Update of Surgical Techniques for Maxillary Sinus Augmentation: A Systematic Literature Review. Implant Dent. 2016 Dec;25(6):839-844. doi: 10.1097/ID.0000000000000467.

    PMID: 27540841BACKGROUND
  • Browaeys H, Bouvry P, De Bruyn H. A literature review on biomaterials in sinus augmentation procedures. Clin Implant Dent Relat Res. 2007 Sep;9(3):166-77. doi: 10.1111/j.1708-8208.2007.00050.x.

    PMID: 17716261BACKGROUND
  • Boyne PJ, James RA. Grafting of the maxillary sinus floor with autogenous marrow and bone. J Oral Surg. 1980 Aug;38(8):613-6. No abstract available.

    PMID: 6993637BACKGROUND
  • Bergamo ETP, Zahoui A, Barrera RB, Huwais S, Coelho PG, Karateew ED, Bonfante EA. Osseodensification effect on implants primary and secondary stability: Multicenter controlled clinical trial. Clin Implant Dent Relat Res. 2021 Jun;23(3):317-328. doi: 10.1111/cid.13007. Epub 2021 May 27.

    PMID: 34047046BACKGROUND
  • Al Madhoun A, Meshal K, Carrio N, Ferres-Amat E, Ferres-Amat E, Barajas M, Jimenez-Escobar AL, Al-Madhoun AS, Saber A, Abou Alsamen Y, Marti C, Atari M. Randomized Clinical Trial: Bone Bioactive Liquid Improves Implant Stability and Osseointegration. J Funct Biomater. 2024 Oct 1;15(10):293. doi: 10.3390/jfb15100293.

    PMID: 39452591BACKGROUND

Related Links

Central Study Contacts

Eslam Osama Hashem, Master's

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident

Study Record Dates

First Submitted

May 30, 2026

First Posted

June 4, 2026

Study Start (Estimated)

October 1, 2026

Primary Completion (Estimated)

October 1, 2028

Study Completion (Estimated)

May 1, 2029

Last Updated

June 4, 2026

Record last verified: 2026-05

Locations